Molecular structure of Eticlopride hydrochloride, CAS Number: 97612-24-3
Eticlopride hydrochloride (CAS 97612-24-3)
Alternate Names:
(−)-Eticlopride
Application:
Eticlopride hydrochloride is a selective D2DR and D3DR antagonist
CAS Number:
97612-24-3
Molecular Weight:
377.31
Molecular Formula:
C17H25ClN2O3•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Eticlopride hydrochloride functions as a selective dopamine D2 receptor antagonist. It acts by binding to the dopamine D2 receptor and inhibiting the binding of dopamine, thereby blocking the downstream signaling pathways associated with this receptor. Eticlopride Hydrochloride′s mechanism of action involves targeting the dopamine D2 receptor and interfering with its normal function, which is for certain experimental studies. By modulating the activity of the dopamine D2 receptor, eticlopride hydrochloride can be used to investigate the role of dopamine signaling in various cellular and molecular processes. Its ability to selectively block the dopamine D2 receptor may be valuable for studying the specific functions and interactions of this receptor in experimental applications.
Eticlopride hydrochloride (CAS 97612-24-3) References
- Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. | Harrison, AA., et al. 2002. Psychopharmacology (Berl). 160: 56-66. PMID: 11862374
- The effects of eticlopride on Morris water task performance in male and female rats neonatally treated with quinpirole. | Brown, RW., et al. 2005. Psychopharmacology (Berl). 180: 234-40. PMID: 15696328
- Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat. | Taylor, JL., et al. 2005. Pharmacol Biochem Behav. 81: 887-93. PMID: 16023708
- Critical involvement of dopaminergic neurotransmission in impulsive decision making. | van Gaalen, MM., et al. 2006. Biol Psychiatry. 60: 66-73. PMID: 16125144
- Behavioral disinhibition requires dopamine receptor activation. | van Gaalen, MM., et al. 2006. Psychopharmacology (Berl). 187: 73-85. PMID: 16767417
- Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex. | Charbit, AR., et al. 2009. J Pharmacol Exp Ther. 331: 752-63. PMID: 19657051
- Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats. | Brennan, KA., et al. 2009. Behav Pharmacol. 20: 688-94. PMID: 19881334
- Dopaminergic modulation of the orbitofrontal cortex affects attention, motivation and impulsive responding in rats performing the five-choice serial reaction time task. | Winstanley, CA., et al. 2010. Behav Brain Res. 210: 263-72. PMID: 20206211
- Effects of blockade of central dopamine D1 and D2 receptors on thermoregulation, metabolic rate and running performance. | Balthazar, CH., et al. 2010. Pharmacol Rep. 62: 54-61. PMID: 20360615
- Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke. | Kuric, E., et al. 2013. Exp Neurol. 247: 202-8. PMID: 23664961
- Divergent circuitry underlying food reward and intake effects of ghrelin: dopaminergic VTA-accumbens projection mediates ghrelin's effect on food reward but not food intake. | Skibicka, KP., et al. 2013. Neuropharmacology. 73: 274-83. PMID: 23770258
- Dopamine D2 Modulation of Sign and Goal Tracking in Rats. | Lopez, JC., et al. 2015. Neuropsychopharmacology. 40: 2096-102. PMID: 25759299
- Systemic D1-R and D2-R antagonists in non-human primates differentially impact learning and memory while impairing motivation and motor performance. | Marino, RA., et al. 2022. Eur J Neurosci. 56: 4121-4140. PMID: 35746869
- Barakol, a natural anxiolytic, inhibits striatal dopamine release but off uptake in vitro. | Thongsaard, W., et al. 1997. Eur J Pharmacol. 319: 157-64. PMID: 9042586
Inhibitor of:
D2DR, and D3DR.Activator of:
OR51M1.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Eticlopride hydrochloride, 10 mg | sc-203576 | 10 mg | $142.00 | |||
Eticlopride hydrochloride, 50 mg | sc-203576A | 50 mg | $597.00 |